Advanced Science, 2023 · DOI: 10.1002/advs.202301639 · Published: October 23, 2023
The study introduces a novel cell delivery platform called the hyper expansion scaffold (HES) designed to improve the efficiency of cell therapies for spinal cord injury (SCI). The HES platform uses a dual driving force model, combining macroscopic swelling forces and microscale capillary action, to facilitate self-promoted and efficient cell absorption, enabling high cell loading. In rat SCI models, the HES loaded with human amniotic epithelial stem cells (hAESCs) promoted functional recovery and axonal projection by reducing neuroinflammation and improving the environment around the injury.
The HES platform provides an efficient method for delivering high densities of cells to injury sites, overcoming limitations of current approaches.
The use of hAESCs and a GMP-compliant preparation process supports the clinical translation of this approach for SCI treatment.
The HES can be packaged independently, enabling long-term storage and convenient clinical administration, which could facilitate the development of standardized, consumable scaffold products.